RecruitingPhase 3NCT04928300

Low Dose Dexmedetomidine Versus Normal Saline in Multiple Fracture Ribs

Diaphragmatic Function, Pain Quality & Anti-inflammatory Properties: A Low Dose Dexmedetomidine Versus Ketamine in Patients With Multiple Fracture Ribs Needing Conservative Treatment


Sponsor

Assiut University

Enrollment

60 participants

Start Date

Jun 12, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

In our study, we assess the diaphragmatic function, pain quality and anti-inflammatory properties between low dose infusion of dexmedetomidine normal saline in patients with multiple fracture ribs on conservative treatment.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 0.9% saline and a drug called Dexmedetomidine for people with rib fractures. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexmedetomidine

low dose dexmedetomidine infusion 0.2 µ/kg/hour IV for 5 days.

OTHER0.9% saline

the same dose and duration of normal saline will be given for 5 days.


Locations(1)

Assiut university hospital

Asyut, Assuit, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04928300


Related Trials